Breast Cancer
Breast Cancer
Advertisement
Natalie Ferguson, DNP, MSN, FNP, MSA, APRNBest Practices | August 23, 2023
Young Black women experience breast cancer at higher rates than their White peers. Here's how you can find out your risks.
Read More
Teresa Hagan Thomas, PhD, RNBreast Cancer | July 20, 2023
Lower education levels, lower income, unemployment, and having more than 1 child were associated with more decision conflict.
Dustin SamplesPatient Voice | July 13, 2023
Survey respondents felt especially displeased when their social circle offered “reassuring” comments.
Dustin SamplesPatient Voice | July 13, 2023
Although recollection may be skewed, many patients reported not being told cancer could recur.
Olivia ThomasBreast Cancer | June 29, 2023
In a qualitative survey, 4 themes emerged that captured the general sentiments of respondents.
Teresa Hagan Thomas, PhD, RNBest Practices | June 22, 2023
This study showed that remote symptom-report monitoring generally results in on-time responses from oncology nurses.
Dustin SamplesConferences | June 9, 2023
Does the route of administration for HER2 targeted therapy affect overall and progression-free survival?
Dustin SamplesConferences | June 9, 2023
Certain intrinsic molecular subtypes changed after metastasis compared to the primary tumor subtype.
Dustin SamplesConferences | June 9, 2023
Overall survival was the least favorable when brain metastasis was diagnosed during or after second-line treatment.
Dustin SamplesConferences | June 9, 2023
According to a novel prognostic model, patients classified as low-risk had better overall survival.
Dustin SamplesConferences | June 8, 2023
Patients with HR+/HER2- early-stage breast cancer classified as H2 were more likely to respond to chemotherapy.
Dustin SamplesConferences | June 8, 2023
Even with a recurrence score <11, patients who were staged higher had worse overall survival.
Dustin SamplesConferences | June 8, 2023
Some organizations recommend annual breast cancer screenings for women over 40, but what is the lifetime cost?
Dustin SamplesConferences | June 8, 2023
Rural residents had lower breast cancer-specific survival and a higher risk of relapse, though the reasoning is unclear.
Dustin SamplesConferences | June 6, 2023
Patients with the UGT1A1 *28/*28 genotype were more likely to experience toxicity leading to discontinuation of SG.
Dustin SamplesConferences | June 6, 2023
Multivariable analysis showed no factors associated with HER2 low compared to HER2- or HER2+ tumors.
Dustin SamplesConferences | June 6, 2023
Male breast cancer is rare, and little has been documented about prognosis, outcomes, and demographics.
Dustin SamplesConferences | June 6, 2023
Do breast satisfaction and sexual well-being play a role in choosing between lumpectomy or mastectomy?
Dustin SamplesConferences | June 1, 2023
The prognosis was worse for Black and young women with MBC, as seen in studies of women with early breast cancer.
Dustin SamplesConferences | June 1, 2023
HER2-low status was associated with better OS and longer time-to-distant recurrence in a single-institution study.
Advertisement
Advertisement
Advertisement